Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS.
On the Structure and functions of gelatinase B/Matrix metalloproteinase-9 in neuroinflammation.
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor.
Effect of a self-management and follow-up program on self-efficacy in patients with multiple sclerosis: a randomized clinical trial.
A Case of Acute Disseminated Encephalomyelitis in a Middle-Aged Adult.
Proteome analysis of post-transplantation recovery mechanisms of an EAE model of multiple sclerosis treated with embryonic stem cell-derived neural precursors.
Optic nerve head component responses of the multifocal electroretinogram in MS.
Teriflunomide for the treatment of multiple sclerosis.
Deep brain stimulation for pain.
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Comparison of 3D Cube FLAIR with 2D FLAIR for Multiple Sclerosis Imaging at 3 Tesla.
From the fundamentals of multiple sclerosis to clinical management.
PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAE.
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas.
Baseline Retinal Nerve Fiber Layer Thickness and Macular Volume Quantified by OCT in the North American Phase 3 Fingolimod Trial for Relapsing-Remitting Multiple Sclerosis.
Epistatic effects on the phenotype of multiple sclerosis.
A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome.
Oligoclonal bands in multiple sclerosis patients: worse prognosis?
Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.
[Progressive multifocal leukoencephalopathy as a complication of natalizumab therapy].
A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies.
Chemokine receptor expression by inflammatory T cells in EAE.
Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6.
Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
The Roles of Vitamin D and Its Analogs in Inflammatory Diseases.

Pages